Clinicopathological and prognostic significance of circulating tumor cells in patients with lung cancer: a meta-analysis

被引:7
作者
Xu, Tingjuan [1 ,2 ]
Shen, Guodong [1 ,2 ]
Cheng, Min [1 ,2 ]
Xu, Weiping [1 ,2 ]
Shen, Gan [1 ,2 ]
Hu, Shilian [1 ,2 ]
机构
[1] Anhui Med Univ, Anhui Prov Hosp, Gerontol Inst Anhui Prov, Hefei 230001, Anhui, Peoples R China
[2] Anhui Prov Key Lab Tumor Immunotherapy & Nutr The, Hefei 230001, Anhui, Peoples R China
基金
中国国家自然科学基金;
关键词
circulating tumor cells; lung cancer; prognosis; clinicopathological parameters; meta-analysis; POLYMERASE-CHAIN-REACTION; CLINICAL-SIGNIFICANCE; PERIPHERAL-BLOOD; MESSENGER-RNA; SURVIVAL; METASTASIS;
D O I
10.18632/oncotarget.19122
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The prognostic significance of circulating tumor cells in patients with lung cancer is controversial. Therefore, we aimed to comprehensively and quantitatively assess the prognostic role of CTCs in patients with lung cancer. Methods: The relevant literature was searched using PubMed, the Cochrane database and the China National Knowledge Internet database (up to June 2016). Using Review Manager 5.1.2, a meta-analysis was performed using hazard ratio (HR), odds ratio (OR) and 95% confidence interval (CI) as effect values. Results: Thirty studies comprising 2,060 patients with lung cancer were analyzed. The pooled HR values showed that circulating tumor cells were significantly correlated with overall survival (HR = 2.63, 95% CI [2.04, 3.39]) and progression-free survival (HR = 3.74, 95% CI [2.49, 5.61]) in these patients. Further subgroup analyses were conducted and categorized by sampling time, detection method, and histological type; these analyses showed the same trend. The pooled OR values showed that circulating tumor cells were associated with non small cell lung cancer stage(OR = 2.11, 95% CI [1.42, 3.14]), small cell lung cancer stage (OR = 10.91, 95% CI [4.10, 29.06]), distant metastasis (OR = 7.06, 95% CI [2.82, 17.66]), lymph node metastasis (OR = 2.31, 95% CI [1.19,4.46]), and performance status(OR = 0.42, 95% CI [0.22, 0.78]). Conclusion: The detection of circulating tumor cells in the peripheral blood of patients with lung cancer can be indicative of a poor prognosis.
引用
收藏
页码:62524 / 62536
页数:13
相关论文
共 45 条
[11]   Lung cancer and its operable brain metastasis:: Survival rate and staging problems [J].
Furák, J ;
Troján, I ;
Szöke, T ;
Agócs, L ;
Csekeö, A ;
Kas, J ;
Svastics, E ;
Eller, J ;
Tiszlavicz, L .
ANNALS OF THORACIC SURGERY, 2005, 79 (01) :241-247
[12]   Circulating tumor cells in small-cell lung cancer: a predictive and prognostic factor [J].
Hiltermann, T. J. N. ;
Pore, M. M. ;
van den Berg, A. ;
Timens, W. ;
Boezen, H. M. ;
Liesker, J. J. W. ;
Schouwink, J. H. ;
Wijnands, W. J. A. ;
Kerner, G. S. M. A. ;
Kruyt, F. A. E. ;
Tissing, H. ;
Tibbe, A. G. J. ;
Terstappen, L. W. M. M. ;
Groen, H. J. M. .
ANNALS OF ONCOLOGY, 2012, 23 (11) :2937-2942
[13]   Relationship of Circulating Tumor Cells to the Effectiveness of Cytotoxic Chemotherapy in Patients With Metastatic Non-Small-Cell Lung Cancer [J].
Hirose, Takashi ;
Murata, Yasunori ;
Oki, Yasunari ;
Sugiyama, Tomohide ;
Kusumoto, Sojiro ;
Ishida, Hiroo ;
Shirai, Takao ;
Nakashima, Masano ;
Yamaoka, Toshimitsu ;
Okuda, Kentaro ;
Ohnishi, Tsukasa ;
Ohmori, Tohru .
ONCOLOGY RESEARCH, 2012, 20 (2-3) :131-137
[14]   Preoperative Circulating Tumor Cell Detection Using the Isolation by Size of Epithelial Tumor Cell Method for Patients with Lung Cancer Is a New Prognostic Biomarker [J].
Hofman, Veronique ;
Bonnetaud, Christelle ;
Ilie, Marius I. ;
Vielh, Philippe ;
Vignaud, Jean Michel ;
Flejou, Jean Francois ;
Lantuejoul, Sylvie ;
Piaton, Eric ;
Mourad, Nadine ;
Butori, Catherine ;
Selva, Eric ;
Poudenx, Michel ;
Sibon, Stephanie ;
Kelhef, Sabrina ;
Venissac, Nicolas ;
Jais, Jean-Philippe ;
Mouroux, Jerome ;
Molina, Thierry Jo ;
Hofman, Paul .
CLINICAL CANCER RESEARCH, 2011, 17 (04) :827-835
[15]   Clinical Significance and Molecular Characteristics of Circulating Tumor Cells and Circulating Tumor Microemboli in Patients With Small-Cell Lung Cancer [J].
Hou, Jian-Mei ;
Krebs, Matthew G. ;
Lancashire, Lee ;
Sloane, Robert ;
Backen, Alison ;
Swain, Rajeeb K. ;
Priest, Lynsey J. C. ;
Greystoke, Alastair ;
Zhou, Cong ;
Morris, Karen ;
Ward, Tim ;
Blackhall, Fiona H. ;
Dive, Caroline .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05) :525-532
[16]  
Huang Tong-hai, 2007, Zhonghua Zhongliu Zazhi, V29, P676
[17]   Circulating tumor cells as a prognostic factor in patients with small cell lung cancer [J].
Igawa, Satoshi ;
Gohda, Keigo ;
Fukui, Tomoya ;
Ryuge, Shinichiro ;
Otani, Sakiko ;
Masago, Akinori ;
Sato, Jun ;
Murakami, Katsuhiro ;
Maki, Sachiyo ;
Katono, Ken ;
Takakura, Akira ;
Sasaki, Jiichiro ;
Satoh, Yukitoshi ;
Masuda, Noriyuki .
ONCOLOGY LETTERS, 2014, 7 (05) :1469-1473
[18]   Detection of Circulating Tumor Cells Using a Novel Immunomagnetic Bead Method in Lung Cancer Patients [J].
Ji, Jin-Ling ;
Jiang, Yu-Zhang ;
Tang, Qian-Qiu ;
He, Xiao-Dong ;
Shen, Zuo-Jun ;
Zhang, Bai-Yin .
JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2016, 30 (05) :656-662
[19]   Prognostic significance of circulating tumor cells in advanced non-small cell lung cancer patients treated with docetaxel and gemcitabine [J].
Juan, O. ;
Vidal, J. ;
Gisbert, R. ;
Munoz, J. ;
Macia, S. ;
Gomez-Codina, J. .
CLINICAL & TRANSLATIONAL ONCOLOGY, 2014, 16 (07) :637-643
[20]   Cancer - The metastasis cascade [J].
Klein, Christoph A. .
SCIENCE, 2008, 321 (5897) :1785-1787